-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $26

Benzinga·08/13/2026 12:52:47
語音播報
Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $24 to $26.